Fundraising Fox

Novoron

San Diego, US · Delaware corporation · 1 known investors

novoron.com ↗

Novoron develops lipoprotein-receptor small molecule therapies aimed at repairing damage and degeneration of the brain and spinal cord, including treatments for proteinopathies and neuroregeneration following traumatic injury. The company focuses on drug discovery for neurological conditions such as neurodegeneration and cognitive decline.

BiotechDeep TechHealthtechMedical Devicesin /novoron-bioscience

Founders & leadership

TS
Travis StilesCEO & Co-founder
SG
Shawn GahrCOO & Co-founder
MG
Michael GoguenDirector
DW
David WeinerExecutive Chairman
RM
Ryan McMillianCFO & Financial Strategy

Investors · 1

Two Bear CapitalWhitefish · $3M – $10M

Reported raises · per SEC filings

Form D private placements
▶$12.1MraisedDec 2022 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Travis StilesExecutive Officer, Director
  • Michael GoguenDirector
  • Shawn GahrExecutive Officer, Director
Offering amount
$12.1M
Amount sold
$12.1M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedJul 2021 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Travis StilesExecutive Officer, Director
  • Shawn GahrDirector
  • Michael GoguenDirector
Offering amount
$3M
Amount sold
$3M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.